moroctocog alfa · Medicine question

Can moroctocog alfa (ReFacto AF) increase cardiovascular risk in patients with existing cardiovascular risk factors?

Name: Can moroctocog alfa (ReFacto AF) increase cardiovascular risk in patients with existing cardiovascular risk factors?
Published: 2026-11-08T01:57:46.347Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, factor VIII replacement therapy with moroctocog alfa (ReFacto AF) may increase cardiovascular risk in patients with existing cardiovascular risk factors.

Sources for this answer

ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringePfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 18Document updated 13 October 2021

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about moroctocog alfa